cytarabine has been researched along with Cognition Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashford, JM; Cheng, C; Conklin, HM; Glass, JO; Jeha, S; Laningham, FH; Nassar, SL; Pui, CH; Reddick, WE; Zhou, Y | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Barrowman, NJ; Dunlap, H; Halton, JM; Hsu, E; Keene, DL; Kuehn, SM; Matzinger, MA; Montour-Proulx, I | 1 |
| Abrey, LE; Anderson, ND; Correa, D; DeAngelis, LM; Glass, A; Mason, WP | 1 |
| Merkle, CJ; Miketova, P; Montgomery, DW; Moore, IM; Salyer, RK; Schaeffer, RC; Torres, BJ | 1 |
| Beck, JD; Ittner, E; Janka, G; Krappmann, P; Lackner, H; Langer, T; Nickel, P; Paulides, M; Plattig, B; Schrappe, M; Stöhr, W | 1 |
| Herzig, GP; Herzig, RH; Karanes, C; Lazarus, HM; Phillips, GL; Wolff, SN | 1 |
| Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK | 1 |
| Bode, U; Deckert-Schlüter, M; Fischer, HP; Glasmacher, A; Kleinschmidt, R; Oehring, R; Pels, H; Schlegel, U | 1 |
| Brown, LD; Colgan, JP; Earle, JD; Krigel, RL; McGinnis, WJ; O'Fallon, JR; O'Neill, BP; Wang, CH | 1 |
| Deelman, BG; Kamps, WA; Kingma, A; Mooyaart, EL; Van Dommelen, RI; Wilmink, JT | 1 |
| Kadan-Lottick, N; Neglia, JP | 1 |
| Andrykowski, MA; Brady, MJ; Gregg, ME; Henslee-Downey, PJ; Lamb, DG; Schmitt, FA | 1 |
| Forio, I; Giralt, J; Olive, T; Ortega, JJ; Salvador, L; Verges, R | 1 |
| Brouwers, P; Fedio, P; Poplack, DG; Riccardi, R | 1 |
| Bluming, AZ; Carbone, PP; Fass, L; Morrow, RH; Ziegler, JL | 1 |
3 trial(s) available for cytarabine and Cognition Disorders
| Article | Year |
|---|---|
Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disorders; Cytarabine; Dexamethasone; Female; Humans; Hydrocortisone; Incidence; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Seizures; Vincristine | 2017 |
The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Psychological Tests; Psychomotor Performance; Radiation Injuries; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vincristine | 1999 |
Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens.
Topics: Adolescent; Age Factors; Brain; Brain Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Humans; Intelligence; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 1992 |
13 other study(ies) available for cytarabine and Cognition Disorders
| Article | Year |
|---|---|
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain; Child; Child, Preschool; Cognition Disorders; Cohort Studies; Cytarabine; Female; Hematinics; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Wechsler Scales | 2005 |
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cognition Disorders; Cytarabine; Drug Screening Assays, Antitumor; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Apoptosis; Caspase 3; Caspases; Cattle; Cell Survival; Cells, Cultured; Cognition Disorders; Colorimetry; Cytarabine; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Humans; Hydrocortisone; Microscopy, Fluorescence; Microscopy, Polarization; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Statistics, Nonparametric | 2006 |
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implicat
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Injections, Spinal; Intelligence Tests; Longitudinal Studies; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Psychomotor Performance; Risk Factors; Vincristine | 2007 |
High-dose cytosine arabinoside therapy for refractory leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Diseases; Cerebellar Ataxia; Cognition Disorders; Conjunctivitis; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Hemorrhage; Humans; Leukemia; Middle Aged | 1983 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine | 1999 |
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Spinal Cord Neoplasms; Survival Analysis; Time Factors | 2000 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition Disorders; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Learning Disabilities; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Netherlands; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Survivors; Teniposide; Treatment Outcome; Vincristine | 2002 |
Pediatric acute lymphoblastic leukemia: redefining outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Drug Administration Routes; Humans; Hydrocortisone; Infant; Learning Disabilities; Memory Disorders; Methotrexate; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survivors; Treatment Outcome | 2002 |
Neuropsychologic impairment in adult bone marrow transplant candidates.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Attention; Bone Marrow Transplantation; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cranial Irradiation; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Memory; Methotrexate; Middle Aged; Neuropsychology; Psychomotor Performance; Regression Analysis; Whole-Body Irradiation | 1992 |
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disorders; Communication Disorders; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neuropsychological Tests; Prednisone; Tomography, X-Ray Computed; Vincristine | 1985 |
Central nervous system involvement in Burkitt's lymphoma.
Topics: Brain Neoplasms; Burkitt Lymphoma; Central Nervous System Diseases; Cerebrospinal Fluid; Cognition Disorders; Cyclophosphamide; Cytarabine; Folic Acid; Humans; Injections, Spinal; Lymphocytosis; Methotrexate; Neoplasm Metastasis; Paraplegia; Vincristine | 1970 |